CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 778 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00981019
NCT00981019N/ACompleted

Study of Primary Care Physicians' Understanding and Use of Different Survival Measures

Max Planck Institute for Human Development·observational·Posted Sep 22, 2009·Updated Aug 15, 2011

In Brief

An observational study for Screening. Completed, enrolled 778 participants across 1 site.

Detailed Summary

The probably most commonly used measure for expressing the pay-offs of early detection and treatment are survival rates. Yet, over time and groups this metric comes with several biases and thus, is not reliable for judging such benefits. Epidemiologists recommend using reduction of disease-specific mortality rates instead, which is unbiased. The purpose of the study is to investigate how primary care physicians understand and use different survival measures for determining the benefit of cancer screening tests.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsScreening
CountriesGermany

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 22, 2009
Enrollment StartDec 1, 2009
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 16.8 years ago